EYPT
EyePoint Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.58
+0.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 499.35x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.37x
- Price / sales
- 141.57x
- Price / cash flow
- -1.48x
Enterprise value
- Enterprise value
- $236.7M
- EV / sales
- 84.89x
- EV / EBITDA
- -0.80x
- EV / EBIT
- -0.75x
- Market cap
- $394.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026